JPMorgan Chase & Co. Issues Pessimistic Forecast for United Therapeutics (NASDAQ:UTHR) Stock Price
United Therapeutics (NASDAQ:UTHR – Free Report) had its price objective trimmed by JPMorgan Chase & Co. from $357.00 to $355.00 in a report released on Monday morning,Benzinga reports. The brokerage currently has an overweight rating on the biotechnology company’s stock. Other research analysts have also recently issued research reports about the company. Bank of America […]
United Therapeutics (NASDAQ:UTHR – Free Report) had its price objective trimmed by JPMorgan Chase & Co. from $357.00 to $355.00 in a report released on Monday morning,Benzinga reports. The brokerage currently has an overweight rating on the biotechnology company’s stock. Other research analysts have also recently issued research reports about the company. Bank of America […]
